Independence Investment Fund Act
- Sponsor
- Rep. Sessions, Pete [R-TX-17]
- Committees
- Financial Services Committee (primary)
- Last action
- Dec 3, 2025
Bottom line
This bill creates a new federal investment fund to strategically deploy capital into critical technology sectors, aiming for both national security benefits and financial self-sustainability while countering foreign adversarial influence.
What it actually does
This bill establishes the Independence Investment Fund within the Department of the Treasury to make seed to mid-stage equity investments in U.S.-headquartered companies developing critical and emerging technologies, with a priority on biotechnology. The Fund aims to enhance national and economic security, signal priorities to private investors, generate financial returns, offer an alternative to adversarial investment, and provide market intelligence to the Federal Government.
Proponents argue
Supporters argue that the bill addresses a critical gap in private sector investment for technologies vital to national security, counters foreign adversarial influence, and fosters domestic innovation, ensuring the U.S. maintains a competitive edge in crucial sectors like biotechnology.
Opponents contend
Critics might contend that the bill represents government overreach into private markets, risks misallocating taxpayer funds, could create moral hazard by distorting investment incentives, or that existing private capital markets are sufficient to meet the identified needs.
The bill is relatively concise and well-structured, making it accessible for an informed reader to understand its core provisions within a reasonable timeframe.
Section 3(a)
Establishment of Independence Investment Fund
This section formally establishes a new entity called the 'Independence Investment Fund' within the Department of the Treasury. This fund is designed to be a government-backed investment vehicle focused on strategic technologies.
Supporters argue
Supporters argue that establishing a dedicated fund is essential to provide a clear institutional home and mandate for strategic investments in critical technologies, signaling a strong federal commitment to these sectors.
Critics contend
Critics might contend that creating new government entities can lead to bureaucratic inefficiencies and mission creep, potentially duplicating efforts of existing agencies or private sector initiatives.
Tradeoffs
The tradeoff is between direct government intervention to address perceived market failures in critical technology sectors and the potential for bureaucratic overhead or distortion of private markets.
Section 3(b)
Objectives of the Fund
The Fund's primary goals are to invest in critical and emerging technologies for national and economic security, signal priorities to private investors, generate financial returns for self-sustainment, offer an alternative to adversarial investment, and provide market intelligence to the Federal Government.
Section 3(c), (d), (e), (f)
Investment Focus and Parameters
The Fund will prioritize biotechnology and make seed to mid-stage equity investments, aiming for an average investment of $1M-$10M, in U.S.-headquartered companies. It retains flexibility to invest in companies headquartered outside the United States (excluding foreign entities of concern) and to partner with foreign venture capital funds, also excluding foreign entities of concern.
Section 3(g), (h)
Advisory and Supervisory Boards
An initial, temporary Advisory Board will recommend the Fund's roadmap and operating guidance, including intellectual property handling and conflict of interest policies. After its sunset, a permanent Supervisory Board will provide ongoing oversight and approve all investment decisions, requiring a supermajority vote (at least 3 of 5 members, with 4 present for quorum).
Section 4
Independent Managing Entity of Fund
The Secretary of the Treasury will select an independent nonprofit or for-profit entity through an open competition to serve as the Fund's managing entity. This entity will be responsible for day-to-day management, developing investment strategy, and providing expert consultation to portfolio companies, operating under specific transparency and conflict-of-interest policies.
Section 8
Authorization of Appropriations
The bill authorizes $975.5 million for fiscal year 2025, with $300 million specifically for biotechnology investments, to remain available until expended. It also authorizes $2 million for administrative costs in FY2025 and $22 million annually for administrative costs from FY2026 through FY2040. A conditional re-authorization of $500 million ($150 million for biotech) is possible for FY2035-2040 if biotech cash balances fall below $80 million.
Defines 'adversarial investment' as capital or intellectual property acquisition from foreign entities of concern, and defines 'foreign entity of concern' by reference to section 10612(a) of the Research and Development, Competition, and Innovation Act (42 U.S.C. 19221(a)).
Section 2(1), (4)
Why it matters:It is standard legislative practice to define terms at the outset of a bill and to reference existing law for consistency and to avoid redundancy, rather than restating lengthy definitions.
Case for: Supporters argue that precise definitions are crucial for the Fund to effectively counter specific threats to national security and prevent circumvention of its objectives, ensuring clarity on prohibited foreign engagements.
Case against: Critics might argue that defining by reference makes it harder for the public and affected companies to understand the full scope of restrictions without looking up external statutes, potentially leading to ambiguity or overly broad interpretations.
Estimated impact: These definitions fundamentally shape the entire scope of the Fund's mission to counter specific foreign threats and dictate which foreign entities are considered problematic for investment purposes.
Explicitly states that Chapter 10 of title 5, United States Code (commonly referred to as the 'Federal Advisory Committee Act' or FACA), shall not apply to either the initial Advisory Board or the permanent Supervisory Board.
Section 3(g)(6), (h)(4)
Why it matters:Potentially to allow for more agile operations and less public scrutiny of board deliberations, which proponents might argue is necessary for sensitive investment decisions and protecting proprietary information related to national security technologies.
Case for: Proponents would argue that exempting the boards from FACA allows for more confidential and efficient deliberations, which is critical for making timely investment decisions and protecting sensitive information related to national security technologies and private companies.
Case against: Opponents might contend that FACA exemptions reduce transparency and public accountability for bodies making significant decisions involving taxpayer funds and national strategy, potentially obscuring conflicts of interest or the rationale behind public investments.
Estimated impact: This exemption significantly reduces public access to board meetings, records, and potentially membership details, impacting the transparency and external oversight of the Fund's governance.
Authorizes the Secretary of the Treasury to appoint not more than 25 personnel without regard to competitive service rules (Title 5, U.S. Code) and to fix their basic pay rates outside standard executive branch classifications, up to the level of annual compensation for the Vice President (Section 102 of Title 3, U.S. Code).
Section 5
Why it matters:This type of authority is often granted to new agencies or funds that require highly specialized expertise and flexibility in hiring, particularly when competing with the private sector for talent. The intent is to enable the Fund to attract top-tier professionals quickly.
Case for: Supporters argue this flexibility is essential to attract top talent from the private sector, who might not otherwise join government service under standard federal hiring and pay rules, ensuring the Fund has the necessary expertise to manage complex investments.
Case against: Critics might argue that such exemptions can lead to inflated salaries, create a two-tiered system within the federal workforce, and reduce accountability and transparency in hiring practices, potentially leading to cronyism.
Estimated impact: Allows for the recruitment of highly specialized and potentially highly compensated staff, significantly influencing the Fund's operational capacity, expertise, and administrative costs, while bypassing traditional federal employment regulations.